[Origin Agritech Limited Reports Unaudited First Quarter Financial Results for Three Months Ended December 31, 2010 Deferred Revenues and Advances from Customers increases 15.71% from RMB 515.7 million at Q1 2010 to RMB 596.7 million at Q1 2011 Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”) BEIJING--(BUSINESS WIRE)--February 22, 2011-- FINANCIAL RESULTS OVERVIEW During the first quarter of fiscal]
[Origin Agritech Limited Reports Unaudited First Quarter Financial Results for Three Months Ended December 31, 2010 Deferred Revenues and Advances from Customers increases 15.71% from RMB 515.7 million at Q1 2010 to RMB 596.7 million at Q1 2011 Origin Agritech Limited (NASDAQ: SEED) (“Origin” or the “Company”) BEIJING--(BUSINESS WIRE)--February 22, 2011-- FINANCIAL RESULTS OVERVIEW During the first quarter of fiscal]
[ASSET PURCHASE AGREEMENT BETWEEN SHOUGUANG CITY HAOYUAN CHEMICAL COMPANY LIMITED, GULF RESOURCES, INC. AND Jinjin Li and Qiuzhen Wang DATED AS OF June 7, 2010 1 1. Asset Checklist 2 This ASSET PURCHASE AGREEMENT (this "AGREEMENT") is entered into as of June 7, 2010 (the "Effective Date") by and between the following Parties: (1) SHOUGUANG CITY HAOYUAN CHEMICAL COMPANY LIMITED,] []
[ASSET PURCHASE AGREEMENT BETWEEN SHOUGUANG CITY HAOYUAN CHEMICAL COMPANY LIMITED, GULF RESOURCES, INC. AND Jinjin Li and Qiuzhen Wang DATED AS OF June 7, 2010 1 1. Asset Checklist 2 This ASSET PURCHASE AGREEMENT (this "AGREEMENT") is entered into as of June 7, 2010 (the "Effective Date") by and between the following Parties: (1) SHOUGUANG CITY HAOYUAN CHEMICAL COMPANY LIMITED,] []
[TPI Reports Record Second Quarter Fiscal Year 2011 Financial Results February 14, 2011 CHENGDU, China, Feb. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the second quarter of Fiscal Year 2011. Second quarter fiscal] [Tianyin Pharmaceutical, Inc. Second Quarter Fiscal Year 2011 Earnings Results February 15, 2011 Operator: Good morning, ladies and gentleman, and thank you for standing by. Welcome to the Tianyin Pharmaceutical Inc. Second Quarter Earnings Conference Call. At this time, all participants are in listen-only mode, and following the presentation, instructions will be given for the question and answer session. Should] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 15, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 7 –]
[TPI Reports Record Second Quarter Fiscal Year 2011 Financial Results February 14, 2011 CHENGDU, China, Feb. 14, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the second quarter of Fiscal Year 2011. Second quarter fiscal] [Tianyin Pharmaceutical, Inc. Second Quarter Fiscal Year 2011 Earnings Results February 15, 2011 Operator: Good morning, ladies and gentleman, and thank you for standing by. Welcome to the Tianyin Pharmaceutical Inc. Second Quarter Earnings Conference Call. At this time, all participants are in listen-only mode, and following the presentation, instructions will be given for the question and answer session. Should] [CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT February 15, 2011 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction (IRS Employer of incorporation) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 Section 7 –]
[] [I, Xiaojun Zhu, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the quarter ended December 31, 2010 of China HGS Real Estate, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [I, Xiaojun Zhu, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the quarter ended December 31, 2010 of China HGS Real Estate, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Xiaojun Zhu, Principal Financial and Accounting Officer]
